The China AI in Telehealth & Telemedicine Market was valued at $431.7 Million in 2025 and projected to reach to $2289.6 Million by 2030, representing a compound annual growth rate of 41.6%. China's AI in telehealth market is poised for exceptional growth through 2030, driven by government digital health mandates, increasing smartphone penetration, and rising healthcare costs.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China's AI in telehealth market is projected to grow from $431.7 million in 2025 to $2,289.6 million by 2030, representing a robust 41.6% CAGR, significantly outpacing the global average of 36.4%.
China's healthcare infrastructure modernization and state-backed digital health policies are accelerating adoption of AI-powered remote consultation platforms, diagnostic tools, and integrated patient management systems across urban and rural regions.
The market is driven by deployment of intelligent diagnostic algorithms, AI-enabled remote consultations, and automated patient triage systems that enhance healthcare accessibility and reduce burden on traditional medical facilities.
China's vast population and uneven distribution of medical resources create significant demand for telemedicine solutions, positioning AI-driven platforms as critical infrastructure for bridging urban-rural healthcare disparities.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | TELEPSYCHIATRY (Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 36.4% from 2025 to 2030 |
| Largest Segment | SOFTWARE (Component) |
| Market Size Base Year (Billions) | ~USD 5.75 (2025) |
| Revenue Forecast (Billions) | ~USD 27.14 (2030) |
| Segments Covered | Component, Modality, Integration Type, Deployment, Function, Application, Type, End User |
8 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PAYERS | 22.6 | 35.1 | 54.2 | 82.6 | 123 | 173.7 | 243.9 | 446 | 42.1 |
| HEALTHCARE PROVIDERS | 56.3 | 87.2 | 134.1 | 203.5 | 301.8 | 424.4 | 593.6 | 1076.8 | 41.5 |
| MEDTECH COMPANIES | 3.5 | 5.3 | 8.1 | 12.2 | 17.8 | 24.8 | 34.3 | 60.7 | 39.9 |
| OTHER END USERS | 3.5 | 5.3 | 7.8 | 11.4 | 16.2 | 21.9 | 29.2 | 47.8 | 35.2 |
| PATIENTS | 25.5 | 39.8 | 61.6 | 94.1 | 140.5 | 198.9 | 280 | 514.5 | 42.4 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 7.8 | 12 | 18.4 | 27.8 | 41.1 | 57.5 | 80 | 143.9 | 40.9 |
| TOTAL | 119.3 | 184.8 | 284.3 | 431.7 | 640.5 | 901.1 | 1260.9 | 2289.6 | 41.6 |
China's AI telehealth market is projected to reach $2,289.6 million by 2030, growing from $431.7 million in 2025.
China's AI in telehealth and telemedicine market is expected to grow at a compound annual growth rate of 41.6% from 2025 to 2030.
Growth in China is driven by government digital health initiatives, healthcare infrastructure modernization, high smartphone penetration, and increasing demand for accessible healthcare services.
China's market includes major tech companies and specialized healthcare AI startups competing to develop remote consultation platforms, diagnostic tools, and patient management systems.
China's 41.6% CAGR significantly exceeds the global average of 36.4%, reflecting stronger market momentum and adoption rates in the country.
The study involved significant activities to estimate the current size of the AI in telehealth & telemedicine market. Exhaustive secondary research was done to collect information on the market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in telehealth & telemedicine market.
This research study used secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The companies offering AI-based telehealth & telemedicine solutions were determined at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.
The secondary research process referred to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in telehealth & telemedicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as CEOs, VPs, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in telehealth market.
After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI-based telemedicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.
In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
Breakdown Of Primary Participants
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in telehealth & telemedicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The market was split into several segments and subsegments after arriving at the overall market size using the market size estimation processes explained above. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Telehealth:Telehealth represents a broad group of healthcare services, including care, education, and other services, made possible through various digital communication technologies; these services are facilitated by telecommunications equipment such as video conferencing, mobile applications, RPM devices, and wearable health technologies. Telehealth offers various services, including preventive care, chronic disease management, mental health support, and virtual consultations. The integration of AI in telehealth enhances remote care by enabling real-time monitoring, virtual assistants, diagnostics, personalized treatment, and predictive analytics.
Telemedicine: Telemedicine is a specific subset of telehealth focused exclusively on remote clinical services. It involves using electronic communications to diagnose, treat, and manage patients without requiring in-person visits. Telemedicine includes real-time video consultations, remote health data monitoring, and the store-and-forward method, where medical information is collected and sent to specialists for evaluation. NLP automates medical documentation and supports AI-powered virtual consultations, reducing administrative burdens on healthcare professionals.
Full forecast, segment splits, and company analysis for all AI in Telehealth & Telemedicine Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report